Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Antibody immunotherapy targeting toxic tau for neurodegenerative disease
TauC3 Biologics is a preclinical biopharmaceutical company developing an antibody-based immunotherapy that targets tauC3, a toxic, truncated form of the tau protein implicated in neurodegenerative disease. Its lead candidate, TBL-100, is a humanized monoclonal antibody developed with LifeArc, designed to selectively…
Infant gut bacteria-derived therapeutic compounds
Bioscopic is a UK biotech developing therapeutic compounds derived from infant gut bacteria to treat cancer and chronic disease. It holds what it describes as the world's largest collection of infant gut bacterial strains, which it uses as a screening platform to identify biologically active compounds. Its lead…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…
Cancer biotherapeutics targeting disease-specific protein isoforms
Isoform Oncology is an early-stage biotechnology company developing cancer therapeutics based on isoform switching and alternative RNA splicing. The company identifies cancer-specific protein variants arising from aberrant splicing and develops biotherapeutics designed to selectively target these disease-specific…